☆ 4.6 Letter

The impact of Omicron on outcomes following infection with SARS-CoV-2 in patients with kidney failure in Scotland

CLINICAL KIDNEY JOURNAL (2023)

Related references

Note: Only part of the references are listed.
Article Urology & Nephrology

The Impact of Vaccination on Incidence and Outcomes of SARS-CoV-2 Infection in Patients with Kidney Failure in Scotland

Samira Bell et al.

Summary: The study in Scotland found that 93% of KRT-treated patients had received two doses of an approved COVID-19 vaccine, but the effectiveness of the vaccine against infection and hospitalization was only 33% and 38%, respectively. Fully vaccinated patients had higher mortality rates and additional strategies are urgently needed to reduce the risk of COVID-19 infection and complications in this population.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

Add to Collection
Letter Medicine, General & Internal

Three-dose vaccination elicits neutralising antibodies against omicron

Mary Wu et al.

LANCET (2022)

Add to Collection
Article Medicine, General & Internal

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study

Nicole Wolter et al.

Summary: According to data analysis from South Africa, individuals infected with the omicron variant have a lower likelihood of hospitalization compared to those infected with non-omicron variants. Furthermore, individuals infected with the omicron variant have a lower odds of severe disease compared to individuals infected with the earlier delta variant.

LANCET (2022)

Add to Collection
Letter Medicine, General & Internal

Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients

Edward J. Carr et al.

LANCET (2022)

Add to Collection
Letter Urology & Nephrology

Seroresponse to Third Doses of SARS-CoV-2 Vaccine Among Patients Receiving Maintenance Dialysis

Caroline M. Hsu et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2022)

Add to Collection
Review Urology & Nephrology

Review of Early Immune Response to SARS-CoV-2 Vaccination Among Patients With CKD

Edward J. Carr et al.

Summary: The effectiveness of SARS-CoV-2 vaccination in CKD patients, particularly transplant recipients and those receiving dialysis, varies in terms of antibody development rates. Further research is needed to evaluate the vaccine efficacy in these populations. Rigorous surveillance is crucial for early detection of potential adverse effects, especially for patients with autoimmune diseases and transplant recipients.

KIDNEY INTERNATIONAL REPORTS (2021)

Add to Collection
Article Urology & Nephrology

COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry

Samira Bell et al.

BMC NEPHROLOGY (2020)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.